Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$263,988,215
+$42,310,827 QoQ
Shares Held
2,054,383
+11.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#111
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. MRK ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,988,215 | 2,054,383 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $221,677,388 | 1,842,858 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $175,280,951 | 1,665,219 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $103,943,108 | 1,238,450 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $96,913,529 | 1,224,274 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $105,021,803 | 1,170,029 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $109,527,877 | 1,101,004 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $125,204,442 | 1,102,540 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $132,196,735 | 1,067,825 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $138,400,507 | 1,048,886 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $126,547,908 | 1,160,777 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $116,704,017 | 1,133,599 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $119,399,917 | 1,034,751 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $104,224,644 | 979,647 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $99,340,524 | 895,363 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $73,638,800 | 855,072 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $65,807,053 | 721,806 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $48,970,393 | 596,836 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,713,628 | 452,944 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,556,208 | 300,309 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $22,494,272 | 289,241 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $51,897,941 | 673,212 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $51,451,767 | 628,995 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $45,926,947 | 553,670 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $48,954,937 | 633,065 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $44,038,745 | 572,378 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||